A phase 2b/3 trial of SYN-010 in patients with irritable bowel syndrome with constipation
Phase of Trial: Phase II/III
Latest Information Update: 27 Jun 2017
At a glance
- Drugs Lovastatin (Primary)
- Indications Irritable bowel syndrome
- Focus Adverse reactions; Therapeutic Use
- 27 Jun 2017 According to a Synthetic Biologics media release, following collaborative discussions with the U.S. Food and Drug Administration (FDA), the company has received the approval for this study.
- 03 Aug 2016 According to a Synthetic Biologics media release, the company plans to initiate this trial in 1Q 2017.
- 10 Mar 2016 According to a Synthetic Biologics media release, the company expects to initiate this trial in the second half of 2016.